Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, subject to certain customary adjustments.
read more
Charles River Laboratories announced that it has completed the acquisition of Vigene Biosciences, Inc. for $292.5 million. In addition to the initial purchase price, the transaction includes additional payments of up to $57.5 million, contingent on ...
read more
Thursday, October 18, 2012
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has been selected by AstraZeneca (NYSE: AZN) as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and ...
read more
Charles River Laboratories has invested in Resero Analytics™, a software company focused on providing solutions to the biopharmaceutical industry to harness its data.
read more
Thursday, November 11, 2021
Charles River Laboratories International, Inc. announced that Birgit Girshick has been promoted to the position of Chief Operating Officer, effective immediately.
read more
Friday, February 15, 2019
Charles River Laboratories has signed a binding offer to acquire Citoxlab for €448 million in cash subject to customary closing adjustments.
read more
Charles River Laboratories has signed a definitive agreement to acquire Vigene Biosciences.
read more
Charles River Laboratories announced the appointment of Dr. Martin Mackay, Executive Vice President, Alexion Pharmaceuticals to its Board of Directors.
read more
Monday, December 23, 2019
Charles River Laboratories announced a definitive agreement to acquire HemaCare for approximately $380 million in cash.
read more
Wednesday, January 30, 2019
Charles River Laboratories and Toxys have entered into an agreement to offer access to ToxTracker in North America.
read more
Wednesday, September 07, 2022
Charles River Laboratories International and Cure AP-4, a non-profit foundation dedicated to raising funds and awareness about Adapter-Protein 4 Hereditary Spastic Paraplegia (AP-4 HSP), have announced a manufacturing collaboration.
read more
Charles River Laboratories International, Inc. and Wheeler Bio, Inc. announced an agreement to implement RightSourceSM at Wheeler Bio’s current good manufacturing practice (CGMP) biologics manufacturing facility in Oklahoma City, OK.
read more
Wednesday, August 24, 2022
Charles River Laboratories International, Inc. announced the addition of five Charles River Accelerator and Development Lab (CRADL™) locations in California and Washington. CRADL provides flexible, turnkey vivarium rental space supported by Charles ...
read more
Charles River Laboratories, International received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell therapy drug products to distribute in Europe, from the European Medicines...
read more
Charles River Laboratories and CHDI Foundation have announced a five-year extension of their ongoing collaboration.
read more